These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4314693)

  • 41. [Growth hormone (HGH) treatment of 7 cases of hyposomatotropism and 1 case of Turner's syndrome].
    Peña J; Tresánchez J; Súarez M; Osorio C
    Rev Clin Esp; 1972 Aug; 126(4):323-6. PubMed ID: 4638604
    [No Abstract]   [Full Text] [Related]  

  • 42. [Thyroid gland function during long-time treatment with homologous somatotropic hormone].
    Willgerodt H; Lässker G; Löbe J
    Dtsch Gesundheitsw; 1971 Aug; 26(33):1564-70. PubMed ID: 5113163
    [No Abstract]   [Full Text] [Related]  

  • 43. The combined effect of growth hormone and methandrostenolone on the linear growth of patients with multiple pituitary hormone deficiencies.
    Pertzelan A; Blum I; Grunebaum M; Laron Z
    Clin Endocrinol (Oxf); 1977 Apr; 6(4):271-6. PubMed ID: 193658
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical experience in the treatment of idiopathic pituitary dwarfism with human growth hormone (KABI)].
    Hibi I; Tanae A; Ozeki T
    Horumon To Rinsho; 1974 May; 22(5):627-36. PubMed ID: 4472959
    [No Abstract]   [Full Text] [Related]  

  • 45. [Hormonal regulation of postnatal growth].
    Suárez M
    Rev Iber Endocrinol; 1968; 15(89):465-511. PubMed ID: 4327213
    [No Abstract]   [Full Text] [Related]  

  • 46. Enhanced linear growth responses in hypopituitary dwarfs treated with growth hormone plus androgen versus growth hormone alone.
    MacGillivray MH; Kolotkin M; Munschauer RW
    Pediatr Res; 1974 Feb; 8(2):103-8. PubMed ID: 4810507
    [No Abstract]   [Full Text] [Related]  

  • 47. Advancement of skeletal age of hypopituitary children treated with thyroid hormone plus cortisone.
    Van den Brande JL; Van Wyk JJ; French FS; Strickland AL; Radcliffe WB
    J Pediatr; 1973 Jan; 82(1):22-7. PubMed ID: 4734131
    [No Abstract]   [Full Text] [Related]  

  • 48. [Treatment of hypophyseal-hypothalamic growth disturbances with homologous somatotropic hormone].
    Lässker G
    Cesk Pediatr; 1972 Oct; 27(10):475. PubMed ID: 5078505
    [No Abstract]   [Full Text] [Related]  

  • 49. [Human growth hormone. Results and indications].
    Job JC
    Rev Prat; 1985 Oct; 35(45):2747-53. PubMed ID: 4089487
    [No Abstract]   [Full Text] [Related]  

  • 50. [Experience with human growth hormone].
    Buzzo RR
    Prensa Med Argent; 1966 Jul; 53(27):1505-8. PubMed ID: 5990486
    [No Abstract]   [Full Text] [Related]  

  • 51. [Diagnostic value of metabolic tests following administration of human growth hormone in the assessment of hypothalamo-hypophyseal dwarfism in children].
    Rybakowa M; Krop J
    Pediatr Pol; 1971 Jun; 46(6):685-94. PubMed ID: 5570510
    [No Abstract]   [Full Text] [Related]  

  • 52. Treatment of pituitary dwarfism with authentic recombinant human growth hormone (SM-9500).
    Takano K; Shizume K; Hibi I; Okuno A; Hanyu K; Suwa S; Nakajima H; Kondo T; Kato K; Iwatani N
    Endocrinol Jpn; 1987 Apr; 34(2):291-7. PubMed ID: 3622395
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Therapy of hypothalamo-hypophyseal growth disorders in childhood using somatotropin].
    Stavratjevová A; Stavratjev M; Lehký M
    Cesk Pediatr; 1979 Jun; 34(6):366-8. PubMed ID: 455536
    [No Abstract]   [Full Text] [Related]  

  • 54. [Endocrine dwarfism. 2. Treatment of hypothalamo-hypophyseal dwarfism and of constitutional dwarfism with postponement of puberty].
    Hesse V
    Kinderarztl Prax; 1975 Apr; 43(4):180-5. PubMed ID: 772271
    [No Abstract]   [Full Text] [Related]  

  • 55. [Initial results in the treatment of pituitary dwarfism using growth hormone].
    Moncada Lorenzo E; Barbería Layana JJ; Morant Ciscar JA; Serrano Martinez M
    Rev Med Univ Navarra; 1975; 19(1):49-61. PubMed ID: 1234782
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [On the management of hypophyseal-hypothalamic dwarfism using human growth hormone].
    Rath F; Waldäusl W
    Wien Klin Wochenschr; 1968 May; 80(18):340 passim. PubMed ID: 5727593
    [No Abstract]   [Full Text] [Related]  

  • 57. [Delay of constitutional development--studies on therapy with growth hormone].
    Butenandt O
    Klin Padiatr; 1984; 196(2):69-72. PubMed ID: 6737950
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Antibody formation to the human growth hormone in its prolonged use in patients with cerebro-hypophyseal nanism].
    Balabolkin MI; Zarubina NA
    Probl Endokrinol (Mosk); 1968; 14(2):1-5. PubMed ID: 5736631
    [No Abstract]   [Full Text] [Related]  

  • 59. [Treatment of pituitary dwarfism with human growth hormone in the course of 3 years].
    Bittel-Dobrzyńska N; Dorant B
    Pediatr Pol; 1977 Aug; 52(8):845-51. PubMed ID: 904989
    [No Abstract]   [Full Text] [Related]  

  • 60. [Studies on the effect of human growth hormone on metabolism in hypophyseal and hypothyroid dwarfism].
    Seige K; Ulrich E
    Z Alternsforsch; 1965 Nov; 18(3):302-10. PubMed ID: 5875434
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.